| Name | Title | Contact Details |
|---|
VeraSuite is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Millions of Patients around the world are standing up and taking an active role in their health, including supporting the care innovations that matter most to them. MedStartr enables patients, doctors, institutions, partners, and investors to find and fund the best ideas in healthcare and bring them to life. Join us today!
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
First Care Clinic is a 501(c)(3) Nonprofit Federally Qualified Health Center providing healthcare services for people of all ages, regardless of the patient’s ability to pay. They offer family medicine, dental health care, and mental health services al...